What's new

Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one Treatment of hyperphenylalaninemia, 20/05/2021 Positive

Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one Treatment of hyperphenylalaninemia, 20/05/2021 Positive

Apr 25, 2025 - 15:03
 0
Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one Treatment of hyperphenylalaninemia, 20/05/2021 Positive
Orphan designation: (S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one Treatment of hyperphenylalaninemia, 20/05/2021 Positive
Read More

Tags:

Previous Article

Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Po...

Next Article

Orphan designation: (14S)-8-[3-(2-{dispiro[2.0.24.13]heptan-7-yl}ethoxy)-1H-pyra...

Related Posts

Summary of opinion: Adcetris, 25/04/2025 Positive

Summary of opinion: Adcetris, 25/04/2025 Positive

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0